Bibliography
Buttar NS, Wang KK, Anderson MA, et al. The effect of selective cyclooxygenase-2 inhibition in Barrett’s esophagus epithelium: an in vitro study. Journal of the National Cancer Institute 2002;94:422-9.
Dvorak K, Chavarria M, Payne CM, et al. Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett’s esophagus. Clinical Cancer Research 2007;13:5305–13.
Wang KK, Sampliner RE, Practice Parameters Committee of the American College of G. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. American Journal of Gastroenterology 2008;103:788–97.
Prasad GA, Wang KK, Buttar NS, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2007;132:1226–33.
Prasad GA, Wang KK, Halling KC, et al. Utility of biomarkers in prediction of response to ablative therapy in Barrett’s esophagus.[see comment]. Gastroenterology 2008;135:370–9.
Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency Ablation in Barrett’s Esophagus with Dysplasia. NEJM 2009; 360:2277–2288
Acknowdegement
Support: NCI grants R01CA097048, R01CA111603, R21CA122426
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, K.K. Endoscopic Treatment for Barrett’s Esophagus and Early Esophageal Cancer. J Gastrointest Surg 14, 946–947 (2010). https://doi.org/10.1007/s11605-009-1144-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-009-1144-8